InVivoMAb anti-human pan-Glypican, Clone: [HS20], Human, Monoclonal

Artikelnummer: BXC-BE0412-INDUSTRIAL
Artikelname: InVivoMAb anti-human pan-Glypican, Clone: [HS20], Human, Monoclonal
Artikelnummer: BXC-BE0412-INDUSTRIAL
Hersteller Artikelnummer: BE0412
Alternativnummer: BXC-BE0412-1MG,BXC-BE0412-5MG,BXC-BE0412-25MG,BXC-BE0412-50MG,BXC-BE0412-100MG
Hersteller: Bio X Cell
Wirt: Human
Kategorie: Antikörper
Immunogen: Not available or unknown
Klonalität: Monoclonal
Konzentration: Lot specific,typically between 4-11 mg/ml
Klon-Bezeichnung: [HS20]
Molekulargewicht: 150 kDa
Pubmed: 24492943
Reinheit: >95%, Determined by SDS-PAGE
Formel: PBS, pH 7.0, Contains no stabilizers or preservatives
Target-Kategorie: GPC3
Anwendungsbeschreibung: in vivo blocking of Wnt signaling, in vitro blocking of Wnt signaling, Functional assays, ELISA, Flow cytometry, Immunoprecipitation
BE0412-INDUSTRIAL